Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen

Inclusion Criteria:

1. Subject is between 50 - 75 years of age.

2. Subject received an explanation about the nature of the study and agrees to providewritten informed consent.

Exclusion Criteria:

1. Subject has dysphagia or any swallowing disorder

2. Subject has congestive heart failure

3. Subject has Diabetes type I.

4. Subject has had prior abdominal surgery other than uncomplicated procedures that wouldbe unlikely to lead to bowel obstruction based on the clinical judgment of theinvestigator

5. Subject has a cardiac pacemaker or other implanted electro medical device.

6. Subject has any allergy or other known contraindication to the medications used in thestudy

7. Subject is expected to undergo MRI examination within 7 days after ingestion of thecapsule.

8. Subject with any condition believed to have an increased risk for capsule retentionsuch as Crohn's disease, intestinal tumors, radiation enteritis, and incompletecolonoscopies due to obstructions or NSAID enteropathy.

9. Subject with gastrointestinal motility disorders

10. Subject has known delayed gastric emptying

11. Subject has any condition, which precludes compliance with study and/or deviceinstructions.

12. Women who are either pregnant or nursing at the time of screening, or are ofchild-bearing potential and do not practice medically acceptable methods ofcontraception.

13. Subject suffers from life threatening conditions

14. Subject currently participating in another clinical study